☰

Rio Boothello - Publications

Affiliations: 
2009-2014 Virginia Commonwealth University, Richmond, VA, United States 
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Morla S, Ravikumar O, O'Hara C, Boothello R, Vera A, Abdelfadiel EI, Fayyad R, Afosah DK, Sharon C, Fernandez L, Shah SA, Patel BB, Desai UR. Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting Anticancer Activity. Journal of Medicinal Chemistry. PMID 36634271 DOI: 10.1021/acs.jmedchem.2c01511  0.706
2022 Boothello RS, Sankaranarayanan NV, Sistla JC, Nagarajan B, Sharon C, Chittum JE, Niyaz RY, Roy S, Nandi A, O'Hara CP, Navaz Gangji R, Afosah DK, Ongolu R, Patel BB, Desai UR. Glycan Modulation of Insulin-like Growth Factor-1 Receptor. Angewandte Chemie (International Ed. in English). PMID 36205924 DOI: 10.1002/anie.202211320  0.586
2022 Boothello RS, Desai U. Thermodynamic Affinity and Nature of Forces Defining Glycosaminoglycan-Protein Systems Using Fluorescence Spectroscopy. Methods in Molecular Biology (Clifton, N.J.). 2303: 259-278. PMID 34626385 DOI: 10.1007/978-1-0716-1398-6_21  0.511
2021 Pingali P, Wu YJ, Boothello R, Sharon C, Li H, Sistla S, Sankaranarayanan NV, Desai UR, Le AT, Doebele RC, Muldoon LL, Patel BB, Neuwelt A. High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity. Neoplasia (New York, N.Y.). 23: 348-359. PMID 33640759 DOI: 10.1016/j.neo.2021.02.001  0.584
2020 Kalita M, Chua JS, Boothello RS, Joice A, Antelope O, Roy A, Anandh Babu PV, Saijoh Y, Desai UR, Kuberan B. Visualizing antithrombin-binding 3--sulfated heparan sulfate motifs on cell surfaces. Chemical Communications (Cambridge, England). PMID 33146178 DOI: 10.1039/d0cc05893a  0.52
2020 Boothello RS, Sankaranarayanan NV, Afosah DK, Karuturi R, Al-Horani RA, Desai UR. Studies on fragment-based design of allosteric inhibitors of human factor XIa. Bioorganic & Medicinal Chemistry. 28: 115762. PMID 32992249 DOI: 10.1016/j.bmc.2020.115762  0.378
2020 Boothello RS, Sankaranarayanan NV, Afosah DK, Karuturi R, Al-Horani RA, Desai UR. Studies on fragment-based design of allosteric inhibitors of human factor XIa. Bioorganic & Medicinal Chemistry. 28: 115762. PMID 32992249 DOI: 10.1016/J.Bmc.2020.115762  0.762
2020 Omar AM, El-Araby ME, Abdelghany TM, Safo MK, Ahmed MH, Boothello R, Patel BB, Abdel-Bakky MS, Malebari AM, Ahmed HEA, Elhaggar RS. Introducing of potent cytotoxic novel 2-(aroylamino)cinnamamide derivatives against colon cancer mediated by dual apoptotic signal activation and oxidative stress. Bioorganic Chemistry. 101: 103953. PMID 32474179 DOI: 10.1016/J.Bioorg.2020.103953  0.368
2019 Sharon C, Boothello R, Vera A, Patel BB. Abstract 4667: A synergistic combination strategy for optimal inhibition of colon cancer stem cells: Simultaneous inhibition of Insulin-like growth factor-1 receptor-AKT-mammalian target of rapamycin axis and the mevalonate-isoprenoid biosynthetic pathway Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-4667  0.469
2018 Boothello RS, Patel NJ, Sharon C, Abdelfadiel EI, Morla S, Brophy DF, Lippman HR, Desai UR, Patel BB. A Unique Non-Saccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. Molecular Cancer Therapeutics. PMID 30337351 DOI: 10.1158/1535-7163.Mct-18-0104  0.733
2018 Afosah DK, Verespy S, Al-Horani RA, Boothello RS, Karuturi R, Desai UR. A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin. Bioorganic & Medicinal Chemistry Letters. PMID 29459207 DOI: 10.1016/J.Bmcl.2018.01.069  0.719
2018 Boothello RS, Patel N, Sharon C, Karuturi R, Abdelfadiel EI, Morla S, Brophy DF, Lippman R, Desai UR, Patel BB. 518 - G2.2, a Unique Non-Sachharide Mimetic of Heparin Hexasaccharide Selectively Inhibits Cancerous but Protects Adult Colonic Stem/Progenitor Cells via a Common Mechanism of Induction of P38 Mitogen-Activated Protein Kinase Gastroenterology. 154: S-114-S-115. DOI: 10.1016/S0016-5085(18)30817-5  0.787
2017 Sankarayanarayanan NV, Strebel TR, Boothello RS, Sheerin K, Raghuraman A, Sallas F, Mosier PD, Watermeyer ND, Oscarson S, Desai UR. A Hexasaccharide Containing Rare 2-O-Sulfate-Glucuronic Acid Residues Selectively Activates Heparin Cofactor II. Angewandte Chemie (International Ed. in English). PMID 28124818 DOI: 10.1002/Anie.201609541  0.78
2016 Patel NJ, Sharon C, Baranwal S, Boothello RS, Desai UR, Patel BB. Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase. Oncotarget. PMID 27705927 DOI: 10.18632/Oncotarget.12358  0.602
2016 Zheng S, Kummarapurugu AB, Afosah DK, Sankaranarayanan NV, Boothello RS, Desai UR, Kennedy T, Voynow JA. 2-O, 3-O Desulfated Heparin Blocks HMGB1 Release by Inhibition of p300 Acetyltransferase Activity. American Journal of Respiratory Cell and Molecular Biology. PMID 27585400 DOI: 10.1165/rcmb.2016-0069OC  0.768
2015 Boothello RS, Sarkar A, Tran VM, Nguyen TK, Sankaranarayanan NV, Mehta AY, Alabbas A, Brown S, Rossi A, Joice AC, Mencio CP, Quintero MV, Kuberan B, Desai UR. Chemoenzymatically Prepared Heparan Sulfate Containing Rare 2-O-Sulfonated Glucuronic Acid Residues. Acs Chemical Biology. 10: 1485-94. PMID 25742429 DOI: 10.1021/Acschembio.5B00071  0.752
2015 Boothello RS, Al-Horani RA, Desai UR. Glycosaminoglycan-protein interaction studies using fluorescence spectroscopy. Methods in Molecular Biology (Clifton, N.J.). 1229: 335-53. PMID 25325964 DOI: 10.1007/978-1-4939-1714-3_27  0.709
2011 Desai BJ, Boothello RS, Mehta AY, Scarsdale JN, Wright HT, Desai UR. Interaction of thrombin with sucrose octasulfate. Biochemistry. 50: 6973-82. PMID 21736375 DOI: 10.1021/Bi2004526  0.759
Show low-probability matches.